Filters: Tags: brodifacoum (X)11 results (71ms)
Brodifacoum toxicity in American kestrels (Falco sparverius) with evidence of increased hazard upon subsequent anticoagulant rodenticide exposure
A seminal question in ecotoxicology is the extent to which contaminant exposure evokes prolonged effects on physiological function and fitness. A series of studies were undertaken with American kestrels ingesting environmentally realistic concentrations of the second-generation anticoagulant rodenticide (SGAR) brodifacoum (BROD). Kestrels fed BROD at 0.3, 1.0 or 3.0 µg/g diet wet wt for 7 d exhibited dose-dependent hemorrhage, histopathological lesions and coagulopathy (prolonged prothrombin and Russell’s viper venom times). Following termination of a 7 d exposure to 0.5 µg BROD/g diet, prolonged blood clotting time returned to baseline values within a week, but BROD residues in liver and kidney (terminal half-life...
A heterologous thrombin clotting time assay (TCT) was used to measure the time for conversion of fibrinogen to fibrin using commercially available reagents. Human reference material included in the kit was diluted with imidazole buffered saline (IBS; 0.0125M imidazole-0.109 M sodium chloride, pH7.4) to generate a standard curve. Each kestrel plasma sample was thawed at 37ºC and diluted with IBS, and following incubation at 37ºC, the reaction was then initiated by the addition of bovine thrombin reagent supplied with the assay kit, with clotting time measured to 0.1 s. Fibrinogen concentration was determined in a single assay for each of the 3 study trials, with reference samples interspersed among study samples....
Range finding trial in which kestrels were fed diets containing varying quantities of brodifacoum and signs of intoxication were monitored.
This dataset describes histopathological changes in liver, kidney, heart, skeletal muscle and intestine of captive American kestrels exposed to the second-generation anticoagulant rodenticide brodifacoum (BROD). The goal of the study was to determine the toxic range of brodifacoum by feeding birds a diet containing 0.3, 1.0, or 3.0 ug BROD/g wet weight. Birds were necropsied and examined grossly for hemorrhages or anemia, and liver, kidney, heart, pectoral muscle, and intestine was collected for histopathological evaluation. Tissues were scanned at least 100x magnification and all lesions, including hemorrhage, inflammation, and degenerative changes, were described and assigned a morphologic diagnosis with severity,...
Anticoagulant rodenticide exposure in Barred Owls (Strix varia) collected in Washington and Oregon 2015-2017
This dataset includes anticoagulant rodenticide (AR) screening results of 40 Barred Owls (Strix varia) collected in forested landscapes of Washington and Oregon from 2015-2017. Liver tissue was collected from each owl and screened for exposure to eight AR compounds, including 4 first-generation ARs (warfarin, diphacinone, chlorophacinone, and coumachlor), and 4 second-generation ARs (brodifacoum, bromadionlone, difethialone, and difenacoum). Additionally, this dataset includes geographic, temporal, environmental, and biological attributes of individual owls that were identified as potential sources of variation in AR exposure and/or useful measurements for assessing AR exposure risk of sympatric northern spotted...
Use of blood clotting assays to assess anticoagulant rodenticide exposure and effects in free-ranging birds of prey
- Observations and treatment of various species of raptorial birds admitted to a rehabilitation facility, and of nestling barn owls observed and sampled in the field - Clotting time parameters (prothrombin time, Russell’s viper venom time, fibrinogen concentration) - Anticoagulant rodenticide residue data
Trial examining blood clotting function response in kestrels initially fed a diet containing chlorophacinone (CPN) or brodifacoum (BROD), and following a recovery period, kestrels were challenged with a diet containing chlorophacinone. Kestrels received two 25 ± 0.1 g NBP meatballs daily for a 7-day period containing either vehicle, 1.5 µg CPN/g wet wt diet (i.e., 1.5 ppm chlorophacinone) or 0.5 µg brodifacoum/g wet wt (i.e., 0.5 ppm brodifacoum) during an initial exposure phase. Following 7 day recovery period, these kestrels were then fed 0.75 µg CPN/g wet wt diet (i.e., 0.75 ppm chlorophacinone) for a 7 day challenge exposure phase. Hereafter, these groups are designated control-chlorophacinone challenge (CON-CPN),...
Citrated plasma samples were sent to the University of Miami Avian and Wildlife Laboratory for clinical determination of total protein, plasma electrophoresis (pre-albumin, albumin, alpha 1 globulins, alpha 2 globulins, beta globulins, gamma globulins) and aspartate aminotransferase and creatine phosphokinase activities.
Trial in which coagulopathy and the time course of recovery of clotting function was determined in kestrels fed a diet containing brodifacoum.
Histopathology of American kestrels (Falco sparverius) sequentially exposed to first and second generation anticoagulant rodenticides
This dataset describes histopathological changes in liver, kidney, heart, skeletal muscle and intestine of captive American kestrels sequentially exposed to first and second generation anticoagulant rodenticides (FGAR and SGAR). The goal of the study was to determine the toxicity of sequential exposure to anticoagulant rodenticides (ARs) by evaluating FGAR-FGAR exposure (7 day chlorophacinone exposure, 7 day recovery, than re-exposure) and SGAR-FGAR exposure (7 day brodifacoum, 7 day recovery, than 7 day exposure to chlorophacinone). Birds were necropsied and examined grossly for hemorrhages or anemia, and liver, kidney, heart, skeletal muscle, and intestine was collected for histopathological evaluation. Tissues...
Acute toxicity and clotting times of anticoagulant rodenticides to red-toothed (Odonus niger) and black (Melichthys niger) triggerfish, fathead minnow (Pimephales promelas), and largemouth bass (Micropterus salmoides)
Acute toxicity and clotting times of anticoagulant rodenticides to four fish species.